NICE Technology Appraisal

Evidence Review

01 June 2016

Surrey Medicines Commissioners Group

Surrey Medicines Commissioning Group recommend that patients prescribed all types of anticoagulants (warfarin and NOACs) should be given an anticoagulant alert card to carry with them. For patients taking NOACs, the card should be annotated on the reverse in the “Therapeutic range (INR)” box with the words “not applicable” or “not required for this drug”. The cards are available for practices to order through usual NHS stationery supply routes. See an example of the Anticoagulant Alert Card in the document below

03 June 2015

Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The PCN supports the use of rivaroxaban as a treatment option in combination with clopidogrel plus aspirin, or aspirin alone, for preventing adverse outcomes after acute management of acute coronary syndrome. To ensure safe implementation of NICE TA335 Acute Trusts need to update their ACS pathway to include rivaroxaban as a treatment option and this should be agreed by the Trust’s DTCs.